Science Applications International Corporation Common Stock

SAICNasdaqCIK 1571123Technology / IT Servicesfiscal year ends January58 quarters since 2012

Revenue, Q2 FY2027
$1.9B
+6.3% on Q2 FY2026
Net income
$102M
−19.7% on Q2 FY2026
Free cash flow
$131M
+13.9% on Q2 FY2026
Diluted EPS
$2.38
−12.2% on Q2 FY2026
Revenue, TTM
$7.4B
trailing four quarters
Net margin, TTM
5.1%
net income $380M
Free cash flow, TTM
$619M
$660M less $41M capex
Cash and equivalents
$126M
long-term debt $2.5B, Jul 31, 2026
Shares, 12-month change
−9.0%
42M shares, Jul 31, 2026
Buybacks, TTM
$479M
7.6% of market value
Dividends, TTM
$67M
1.1% of market value
Market value
$6.3B
at the close, buybacks

Latest quarter Q2 FY2027, filed August 31, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2027, the quarter ended July 31, 2026, Science Applications International Corporation Common Stock reported revenue of $1.9B, +6.3% on Q2 FY2026, and net income of $102M (−19.7%). Operating margin was 8.1%. Free cash flow, operating cash flow less capital expenditures, was $131M ($146M less $15M). Diluted earnings per share were $2.38.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

SAIC daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $151.37 · H $151.77 · L $149.80 · C $150.24 · −0.66% on the dayOver the range: +67.66%, Nov 14, 2025 to Nov 13, 2026
$77$97$118$139$160Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q3 FY2023 to Q2 FY2027, through the filing of August 31, 2026.

Revenue and net incomeRevenueNet income
$0$1B$2B$3BQ3'23, Revenue: $1.9BQ3'23, Net income: $80MQ3'23Q4'23, Revenue: $2.0BQ4'23, Net income: $74MQ4'23Q1'24, Revenue: $2.0BQ1'24, Net income: $98MQ1'24Q2'24, Revenue: $1.8BQ2'24, Net income: $247MQ2'24Q3'24, Revenue: $1.9BQ3'24, Net income: $93MQ3'24Q4'24, Revenue: $1.7BQ4'24, Net income: $39MQ4'24Q1'25, Revenue: $1.8BQ1'25, Net income: $77MQ1'25Q2'25, Revenue: $1.8BQ2'25, Net income: $81MQ2'25Q3'25, Revenue: $2.0BQ3'25, Net income: $106MQ3'25Q4'25, Revenue: $1.8BQ4'25, Net income: $98MQ4'25Q1'26, Revenue: $1.9BQ1'26, Net income: $68MQ1'26Q2'26, Revenue: $1.8BQ2'26, Net income: $127MQ2'26Q3'26, Revenue: $1.9BQ3'26, Net income: $78MQ3'26Q4'26, Revenue: $1.8BQ4'26, Net income: $85MQ4'26Q1'27, Revenue: $1.9BQ1'27, Net income: $115MQ1'27Q2'27, Revenue: $1.9BQ2'27, Net income: $102MQ2'27$0$1B$2B$3BQ3'23, Revenue: $1.9BQ3'23, Net income: $80MQ3'23Q4'23, Revenue: $2.0BQ4'23, Net income: $74MQ4'23Q1'24, Revenue: $2.0BQ1'24, Net income: $98MQ1'24Q2'24, Revenue: $1.8BQ2'24, Net income: $247MQ2'24Q3'24, Revenue: $1.9BQ3'24, Net income: $93MQ3'24Q4'24, Revenue: $1.7BQ4'24, Net income: $39MQ4'24Q1'25, Revenue: $1.8BQ1'25, Net income: $77MQ1'25Q2'25, Revenue: $1.8BQ2'25, Net income: $81MQ2'25Q3'25, Revenue: $2.0BQ3'25, Net income: $106MQ3'25Q4'25, Revenue: $1.8BQ4'25, Net income: $98MQ4'25Q1'26, Revenue: $1.9BQ1'26, Net income: $68MQ1'26Q2'26, Revenue: $1.8BQ2'26, Net income: $127MQ2'26Q3'26, Revenue: $1.9BQ3'26, Net income: $78MQ3'26Q4'26, Revenue: $1.8BQ4'26, Net income: $85MQ4'26Q1'27, Revenue: $1.9BQ1'27, Net income: $115MQ1'27Q2'27, Revenue: $1.9BQ2'27, Net income: $102MQ2'27$0$1B$2B$3BQ3'23, Revenue: $1.9BQ3'23, Net income: $80MQ4'23, Revenue: $2.0BQ4'23, Net income: $74MQ4'23Q1'24, Revenue: $2.0BQ1'24, Net income: $98MQ2'24, Revenue: $1.8BQ2'24, Net income: $247MQ2'24Q3'24, Revenue: $1.9BQ3'24, Net income: $93MQ4'24, Revenue: $1.7BQ4'24, Net income: $39MQ4'24Q1'25, Revenue: $1.8BQ1'25, Net income: $77MQ2'25, Revenue: $1.8BQ2'25, Net income: $81MQ2'25Q3'25, Revenue: $2.0BQ3'25, Net income: $106MQ4'25, Revenue: $1.8BQ4'25, Net income: $98MQ4'25Q1'26, Revenue: $1.9BQ1'26, Net income: $68MQ2'26, Revenue: $1.8BQ2'26, Net income: $127MQ2'26Q3'26, Revenue: $1.9BQ3'26, Net income: $78MQ4'26, Revenue: $1.8BQ4'26, Net income: $85MQ4'26Q1'27, Revenue: $1.9BQ1'27, Net income: $115MQ2'27, Revenue: $1.9BQ2'27, Net income: $102MQ2'27

Net income losses drawn in red.

Free cash flow
$0$100M$200M$300MQ3'23, Free cash flow: $122MQ3'23Q4'23, Free cash flow: $138MQ4'23Q1'24, Free cash flow: $76MQ1'24Q2'24, Free cash flow: $144MQ2'24Q3'24, Free cash flow: $97MQ3'24Q4'24, Free cash flow: $52MQ4'24Q1'25, Free cash flow: $92MQ1'25Q2'25, Free cash flow: $132MQ2'25Q3'25, Free cash flow: $134MQ3'25Q4'25, Free cash flow: $100MQ4'25Q1'26, Free cash flow: $92MQ1'26Q2'26, Free cash flow: $115MQ2'26Q3'26, Free cash flow: $120MQ3'26Q4'26, Free cash flow: $250MQ4'26Q1'27, Free cash flow: $118MQ1'27Q2'27, Free cash flow: $131MQ2'27$0$100M$200M$300MQ3'23, Free cash flow: $122MQ3'23Q4'23, Free cash flow: $138MQ4'23Q1'24, Free cash flow: $76MQ1'24Q2'24, Free cash flow: $144MQ2'24Q3'24, Free cash flow: $97MQ3'24Q4'24, Free cash flow: $52MQ4'24Q1'25, Free cash flow: $92MQ1'25Q2'25, Free cash flow: $132MQ2'25Q3'25, Free cash flow: $134MQ3'25Q4'25, Free cash flow: $100MQ4'25Q1'26, Free cash flow: $92MQ1'26Q2'26, Free cash flow: $115MQ2'26Q3'26, Free cash flow: $120MQ3'26Q4'26, Free cash flow: $250MQ4'26Q1'27, Free cash flow: $118MQ1'27Q2'27, Free cash flow: $131MQ2'27$0$100M$200M$300MQ3'23, Free cash flow: $122MQ4'23, Free cash flow: $138MQ4'23Q1'24, Free cash flow: $76MQ2'24, Free cash flow: $144MQ2'24Q3'24, Free cash flow: $97MQ4'24, Free cash flow: $52MQ4'24Q1'25, Free cash flow: $92MQ2'25, Free cash flow: $132MQ2'25Q3'25, Free cash flow: $134MQ4'25, Free cash flow: $100MQ4'25Q1'26, Free cash flow: $92MQ2'26, Free cash flow: $115MQ2'26Q3'26, Free cash flow: $120MQ4'26, Free cash flow: $250MQ4'26Q1'27, Free cash flow: $118MQ2'27, Free cash flow: $131MQ2'27

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$1B$2B$3BQ3'23, Cash and equivalents: $53MQ3'23, Long-term debt: $2.4BQ3'23Q4'23, Cash and equivalents: $109MQ4'23, Long-term debt: $2.3BQ4'23Q1'24, Cash and equivalents: $422MQ1'24, Long-term debt: $2.3BQ1'24Q2'24, Cash and equivalents: $352MQ2'24, Long-term debt: $2.2BQ2'24Q3'24, Cash and equivalents: $311MQ3'24, Long-term debt: $2.2BQ3'24Q4'24, Cash and equivalents: $94MQ4'24, Long-term debt: $2.0BQ4'24Q1'25, Cash and equivalents: $49MQ1'25, Long-term debt: $2.0BQ1'25Q2'25, Cash and equivalents: $48MQ2'25, Long-term debt: $2.0BQ2'25Q3'25, Cash and equivalents: $46MQ3'25, Long-term debt: $1.9BQ3'25Q4'25, Cash and equivalents: $56MQ4'25, Long-term debt: $1.9BQ4'25Q1'26, Cash and equivalents: $47MQ1'26, Long-term debt: $1.9BQ1'26Q2'26, Cash and equivalents: $48MQ2'26, Long-term debt: $1.8BQ2'26Q3'26, Cash and equivalents: $45MQ3'26, Long-term debt: $2.5BQ3'26Q4'26, Cash and equivalents: $182MQ4'26, Long-term debt: $2.5BQ4'26Q1'27, Cash and equivalents: $109MQ1'27, Long-term debt: $2.5BQ1'27Q2'27, Cash and equivalents: $126MQ2'27, Long-term debt: $2.5BQ2'27$0$1B$2B$3BQ3'23, Cash and equivalents: $53MQ3'23, Long-term debt: $2.4BQ3'23Q4'23, Cash and equivalents: $109MQ4'23, Long-term debt: $2.3BQ4'23Q1'24, Cash and equivalents: $422MQ1'24, Long-term debt: $2.3BQ1'24Q2'24, Cash and equivalents: $352MQ2'24, Long-term debt: $2.2BQ2'24Q3'24, Cash and equivalents: $311MQ3'24, Long-term debt: $2.2BQ3'24Q4'24, Cash and equivalents: $94MQ4'24, Long-term debt: $2.0BQ4'24Q1'25, Cash and equivalents: $49MQ1'25, Long-term debt: $2.0BQ1'25Q2'25, Cash and equivalents: $48MQ2'25, Long-term debt: $2.0BQ2'25Q3'25, Cash and equivalents: $46MQ3'25, Long-term debt: $1.9BQ3'25Q4'25, Cash and equivalents: $56MQ4'25, Long-term debt: $1.9BQ4'25Q1'26, Cash and equivalents: $47MQ1'26, Long-term debt: $1.9BQ1'26Q2'26, Cash and equivalents: $48MQ2'26, Long-term debt: $1.8BQ2'26Q3'26, Cash and equivalents: $45MQ3'26, Long-term debt: $2.5BQ3'26Q4'26, Cash and equivalents: $182MQ4'26, Long-term debt: $2.5BQ4'26Q1'27, Cash and equivalents: $109MQ1'27, Long-term debt: $2.5BQ1'27Q2'27, Cash and equivalents: $126MQ2'27, Long-term debt: $2.5BQ2'27$0$1B$2B$3BQ3'23, Cash and equivalents: $53MQ3'23, Long-term debt: $2.4BQ4'23, Cash and equivalents: $109MQ4'23, Long-term debt: $2.3BQ4'23Q1'24, Cash and equivalents: $422MQ1'24, Long-term debt: $2.3BQ2'24, Cash and equivalents: $352MQ2'24, Long-term debt: $2.2BQ2'24Q3'24, Cash and equivalents: $311MQ3'24, Long-term debt: $2.2BQ4'24, Cash and equivalents: $94MQ4'24, Long-term debt: $2.0BQ4'24Q1'25, Cash and equivalents: $49MQ1'25, Long-term debt: $2.0BQ2'25, Cash and equivalents: $48MQ2'25, Long-term debt: $2.0BQ2'25Q3'25, Cash and equivalents: $46MQ3'25, Long-term debt: $1.9BQ4'25, Cash and equivalents: $56MQ4'25, Long-term debt: $1.9BQ4'25Q1'26, Cash and equivalents: $47MQ1'26, Long-term debt: $1.9BQ2'26, Cash and equivalents: $48MQ2'26, Long-term debt: $1.8BQ2'26Q3'26, Cash and equivalents: $45MQ3'26, Long-term debt: $2.5BQ4'26, Cash and equivalents: $182MQ4'26, Long-term debt: $2.5BQ4'26Q1'27, Cash and equivalents: $109MQ1'27, Long-term debt: $2.5BQ2'27, Cash and equivalents: $126MQ2'27, Long-term debt: $2.5BQ2'27

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2027 filed August 31, 2026.

Science Applications International Corporation Common Stock income statement, quarterly
Millions of dollarsQ2 FY2027ended Jul 31, 2026filed Aug 31, 2026Q1 FY2027ended May 1, 2026filed Jun 1, 2026Q4 FY2026ended Jan 30, 2026filed Mar 16, 2026Q3 FY2026ended Oct 31, 2025filed Dec 4, 2025Q2 FY2026ended Aug 1, 2025filed Sep 4, 2025Q1 FY2026ended May 2, 2025filed Jun 2, 2025Q4 FY2025ended Jan 31, 2025filed Mar 17, 2025Q3 FY2025ended Nov 1, 2024filed Dec 5, 2024YoYQ2 FY2027vs Q2 FY2026
Revenue1,8801,9061,7501,8661,7691,8771,8381,976+6.3%
Cost of revenue1,6411,6571,5291,6391,5541,6681,6061,739+5.6%
Gross profit—————————
Research and development—————————
Selling, general and administrative87838510175899483+16.0%
Operating income152179133128139121138160+9.4%
Other income (expense)0(1)0(1)0(5)(2)(2)—
Pretax income119145999410886107126+10.2%
Income tax17301416(19)18920+189.5%
Net income10211585781276898106−19.7%
Diluted EPS ($)2.382.61—1.692.711.42—2.13−12.2%
Diluted shares (millions)4344—464748—50—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2027 filed August 31, 2026.

Science Applications International Corporation Common Stock balance sheet, quarterly
Millions of dollarsQ2 FY2027ended Jul 31, 2026filed Aug 31, 2026Q1 FY2027ended May 1, 2026filed Jun 1, 2026Q4 FY2026ended Jan 30, 2026filed Mar 16, 2026Q3 FY2026ended Oct 31, 2025filed Dec 4, 2025Q2 FY2026ended Aug 1, 2025filed Sep 4, 2025Q1 FY2026ended May 2, 2025filed Jun 2, 2025Q4 FY2025ended Jan 31, 2025filed Mar 17, 2025Q3 FY2025ended Nov 1, 2024filed Dec 5, 2024YoYQ2 FY2027vs Q2 FY2026
Cash and equivalents1261091824548475646+162.5%
Short-term investments—————————
Total current assets1,2791,1991,1791,2571,2041,1481,1541,160+6.2%
Total assets5,4235,3385,3545,4235,2015,2115,2465,275+4.3%
Total current liabilities1,0621,0379821,0501,4471,4741,3961,337−26.6%
Long-term debt2,4522,4602,4682,4751,8441,8761,9071,939+33.0%
Total debt2,4852,4862,4872,4872,2922,2812,2202,159+8.4%
Total liabilities—————————
Stockholders’ equity1,4361,4231,5001,5121,5171,5051,5771,612−5.3%
Shares outstanding (millions)4242434546474849—

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2027 filed August 31, 2026.

Science Applications International Corporation Common Stock cash flow statement, quarterly
Millions of dollarsQ2 FY2027ended Jul 31, 2026filed Aug 31, 2026Q1 FY2027ended May 1, 2026filed Jun 1, 2026Q4 FY2026ended Jan 30, 2026filed Mar 16, 2026Q3 FY2026ended Oct 31, 2025filed Dec 4, 2025Q2 FY2026ended Aug 1, 2025filed Sep 4, 2025Q1 FY2026ended May 2, 2025filed Jun 2, 2025Q4 FY2025ended Jan 31, 2025filed Mar 17, 2025Q3 FY2025ended Nov 1, 2024filed Dec 5, 2024YoYQ2 FY2027vs Q2 FY2026
Operating cash flow146127258129122100115143+19.7%
Capital expenditures1598978159+114.3%
Free cash flow (CFO − capex)13111825012011592100134+13.9%
Depreciation and amortization3940(79)383536(79)35+11.4%
Share repurchases981889895110142133121−10.9%
Dividends paid1617171717191818−5.9%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2026 filed March 16, 2026.

Income statement

Science Applications International Corporation Common Stock income statement, annual
Millions of dollarsFY2026ended Jan 30, 2026filed Mar 16, 2026FY2025ended Jan 31, 2025filed Mar 17, 2025FY2024ended Feb 2, 2024filed Mar 20, 2024FY2023ended Feb 3, 2023filed Apr 3, 2023FY2022ended Jan 28, 2022filed Mar 28, 2022FY2021ended Jan 29, 2021filed Mar 26, 2021FY2020ended Jan 31, 2020filed Mar 27, 2020FY2019ended Feb 1, 2019filed Mar 29, 2019FY2018ended Feb 2, 2018filed Mar 29, 2018FY2017ended Feb 3, 2017filed Mar 30, 2017FY2016ended Jan 29, 2016filed Mar 29, 2016FY2015ended Jan 30, 2015filed Mar 31, 2015FY2014ended Jan 31, 2014filed Apr 9, 2014FY2013ended Jan 31, 2013filed Oct 15, 2013FY2012ended Jan 31, 2012filed Oct 15, 2013
Revenue7,2627,4797,4447,7047,3947,0566,3794,6594,4544,4424,3153,8854,1214,7814,733
Cost of revenue6,3906,5876,5726,8166,5356,2645,6734,1954,0434,0033,9043,5503,7884,3734,307
Gross profit———————————————
Research and development13124146754445438
Selling, general and administrative350339373374344352288158155166184959299127
Operating income521563741501462390370220256263227240183281299
Other income (expense)(6)(9)(1)(8)13632100——(1)
Pretax income387428620375358271286170214212183223176281298
Income tax29661437279605733356966826399116
Net income358362477300277209226137179143117141113182182
Diluted EPS ($)7.707.178.885.384.773.563.833.114.023.122.472.912.273.663.66
Diluted shares (millions)475154565859594445464749505050

Balance sheet

Science Applications International Corporation Common Stock balance sheet, annual
Millions of dollarsFY2026ended Jan 30, 2026filed Mar 16, 2026FY2025ended Jan 31, 2025filed Mar 17, 2025FY2024ended Feb 2, 2024filed Mar 20, 2024FY2023ended Feb 3, 2023filed Apr 3, 2023FY2022ended Jan 28, 2022filed Mar 28, 2022FY2021ended Jan 29, 2021filed Mar 26, 2021FY2020ended Jan 31, 2020filed Mar 27, 2020FY2019ended Feb 1, 2019filed Mar 29, 2019FY2018ended Feb 2, 2018filed Mar 29, 2018FY2017ended Feb 3, 2017filed Mar 30, 2017FY2016ended Jan 29, 2016filed Mar 29, 2016FY2015ended Jan 30, 2015filed Mar 31, 2015FY2014ended Jan 31, 2014filed Apr 9, 2014FY2013ended Jan 31, 2013filed Oct 15, 2013FY2012ended Jan 31, 2012filed Oct 15, 2013
Cash and equivalents182569410910617118823714421019530125411
Short-term investments———————————————
Total current assets1,1791,1541,1311,1971,2631,2891,4301,433950901952942994809—
Total assets5,3545,2465,3145,5435,7465,7234,7114,5632,0732,0422,1221,3891,4471,245—
Total current liabilities9821,3961,1581,1261,3521,2751,128897695623688552564638—
Long-term debt2,4681,9072,0222,3432,3702,4471,8512,0659831,0221,01345448911
Total debt2,4872,2202,0992,3742,5182,5151,9212,0891,0241,0471,07048650233
Total liabilities———————————————
Stockholders’ equity1,5001,5771,7851,6941,6191,5421,4171,485327349380345377596656
Shares outstanding (millions)43485254565858594244454648——

Cash flow statement

Science Applications International Corporation Common Stock cash flow statement, annual
Millions of dollarsFY2026ended Jan 30, 2026filed Mar 16, 2026FY2025ended Jan 31, 2025filed Mar 17, 2025FY2024ended Feb 2, 2024filed Mar 20, 2024FY2023ended Feb 3, 2023filed Apr 3, 2023FY2022ended Jan 28, 2022filed Mar 28, 2022FY2021ended Jan 29, 2021filed Mar 26, 2021FY2020ended Jan 31, 2020filed Mar 27, 2020FY2019ended Feb 1, 2019filed Mar 29, 2019FY2018ended Feb 2, 2018filed Mar 29, 2018FY2017ended Feb 3, 2017filed Mar 30, 2017FY2016ended Jan 29, 2016filed Mar 29, 2016FY2015ended Jan 30, 2015filed Mar 31, 2015FY2014ended Jan 31, 2014filed Apr 9, 2014FY2013ended Jan 31, 2013filed Oct 15, 2013FY2012ended Jan 31, 2012filed Oct 15, 2013
Operating cash flow609494396532518755458184217273226————
Capital expenditures3236272536462128221520221676
Free cash flow (CFO − capex)577458369507482709437156195258206————
Depreciation and amortization302526323732362346232619111015
Share repurchases44555838226722634197691861806914913——
Dividends paid70757983868787535454555227——

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$133K
1 purchases by 1 insider; officers and directors $133K
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$479K
7 purchases by 6 insiders; officers and directors $479K
Sold, twelve months
$0
0 sales by 0 insiders; officers and directors $0

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Sep 22, 2026Cush C. DavidDirectoropen-market buyindirect1,000$132.50$133K1,000Sep 22, 2026
Sep 4, 2026Benson David CDirectoraward1,220$0.00—1,220Sep 9, 2026
Sep 4, 2026DiFronzo Vincent P.EVP,-Air Force & Space, Intelaward4,210$0.00—6,477Sep 9, 2026
Sep 4, 2026Cush C. DavidDirectoraward1,220$0.00—1,220Sep 9, 2026
Jul 2, 2026DiFronzo Vincent P.EVP,-Air Force & Space, Intelgift2,682$0.00—2,267Jul 6, 2026
Jul 2, 2026DiFronzo Vincent P.EVP,-Air Force & Space, Intelgiftindirect2,682$0.00—9,856Jul 6, 2026
Jun 6, 2026McCarthy Kathleen T.EVP, CHROtax withholding1,233$114.35$141K12,014Jun 9, 2026
Jun 3, 2026Urban DavidDirectoraward1,886$0.00—3,139Jun 4, 2026
Jun 3, 2026Tien John K JrDirectoraward1,886$0.00—4,449Jun 4, 2026
Jun 3, 2026Shane Steven RDirectoraward1,886$0.00—39,971Jun 4, 2026
Jun 3, 2026Rogers Michael ScottDirectoraward2,174$0.00—2,174Jun 4, 2026
Jun 3, 2026Morea Donna SDirectoraward1,886$0.00—37,040Jun 4, 2026
Jun 3, 2026McGuirt Milford WDirectoraward1,886$0.00—10,371Jun 4, 2026
Jun 3, 2026Mcfarland Katharina G.Directoraward1,886$0.00—10,624Jun 4, 2026
Jun 3, 2026Handlon Carolyn BDirectoraward1,886$0.00—7,562Jun 4, 2026
Jun 3, 2026Eremenko PaulDirectoraward2,174$0.00—2,174Jun 4, 2026
Jun 3, 2026Reagan JamesCEO, Directortax withholding742$113.36$84K46,950Jun 4, 2026
Jun 2, 2026Shane Steven RDirectoroption exercise2,876$77.65$223K40,026Jun 3, 2026
Jun 2, 2026Shane Steven RDirectortax withholding1,941$115.08$223K38,085Jun 3, 2026
Apr 9, 2026Attili SrinivasEVP, Civilianopen-market buy100$94.96$9K17,656Apr 13, 2026
Apr 7, 2026Morea Donna SDirectoroption exercise2,876$77.65$223K37,397Apr 8, 2026
Apr 7, 2026Morea Donna SDirectortax withholding2,243$99.57$223K35,154Apr 8, 2026
Apr 7, 2026Natarajan PrabuEVP, Chief Financial Officertax withholding837$99.57$83K70,566Apr 8, 2026
Apr 7, 2026Hageman HilaryEVP General Counsel, Secretarytax withholding670$99.57$67K26,618Apr 8, 2026
Apr 7, 2026DiFronzo Vincent P.EVP,-Air Force & Space, Inteltax withholding234$99.57$23K4,949Apr 8, 2026

Full insider history for Science Applications International Corporation Common Stock, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held SAIC in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded SAIC by quarter.

FundManagerQuarterValueSharesWeightMove
Renaissance TechnologiesPeter BrownQ3 2026$10M79,8500.01%trimmed −37.3%

Sources

Fiscal year ends in month 1; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
Science Applications International Corporation, CIK 1571123 on EDGAR
Extract generated
November 16, 2026
Withheld
none
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues
Cost of revenue: CostOfRevenue
Gross profit: not filed
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss, ProfitLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total debt: LongTermDebt, noncurrent+current, with finance leases
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/SAIC.json